Cloud DX (TSX-V:CDX, OTCQB:CDXFF) announced that in a show of their support for the company, a group of its investors have agreed to convert approximately C$4.2 million in total debt to shares ahead of the maturity date. It said the average conversion price was C$0.154 per share, a premium to the current market price of $0.09 before Tuesday’s opening bell in Toronto. The company said...
Atossa Therapeutics Inc (NASDAQ:ATOS), a company specializing in developing pharmaceuticals, has announced that a pre-menopausal breast cancer patient has completed a successful five-year treatment using its drug (Z)-endoxifen. The Seattle-based company reported that the patient, diagnosed with Estrogen Receptor positive (ER+) / Human Epidermal Growth Factor Receptor 2 negative (HER2-)...
Spectral AI Inc (NASDAQ:MDAI) announced that it has received a $1 million investment from an affiliate of its largest shareholder into its newly created subsidiary Spectral IP. Spectral IP will be focused on developing intellectual property for the broader AI ecosystem through acquisitions, strategic partnerships, and collaborations with AI technology providers, healthcare institutions,...
Predictiv AI Inc (TSX-V:PAI) announced a private placement of 12.5 million units priced at $0.02 each, targeting around $250,000. Each unit includes a share and warrant exercisable at $0.05 within 24 months. The company also initiated debt settlement agreements with certain officers, directors, and consultants, converting $500,000 in payables into Predictiv AI shares. The company plans to...
Filament Health Corp (NEO:FH, OTCQB:FLHLF) announced that since March 1, 2024, it has shipped its botanical psilocybin drug candidate PEX010 to four countries for it to be used in clinical trials at leading research institutions. The company said that PEX010 will be studied in the United States, Canada, Belgium, and Israel for a range of mental health indications, including cannabis use...